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Abstract 
Organophosphorus compounds (OPs) such as sarin, soman, and tabun are toxic nerve 
agents used in chemical warfare and as pesticides. These OPs covalently bond with Ser203, a 
catalytic residue in the enzyme acetylcholinesterase (AChE), preventing hydrolysis of the 
neurotransmitter acetylcholine into acetate and choline. Once exposed to an OP compound, 
the inhibited AChE will undergo an irreversible process known as aging, where the OP-AChE 
complex will dealkylate and form a stable phosphonate anion on the Ser203 residue, inactivating 
the enzyme. Without functioning AChE, acetylcholine accumulates in the central nervous 
system causing seizures, vomiting, and often death. Currently, there are no known therapeutic 
methods to reverse this aging process to regain enzymatic activity.  
However, inhibited AChE can be restored to the active AChE before the onset of the 
aging process by treatment with pharmaceuticals containing an oxime functional group. The 
goal of this project is to discover a compound that will realkylate the phosphonate group on the 
Ser203 in aged-AChE, which can then be restored to the active AChE by oxime treatment. 
Literature shows that quinone methides (QMs) are capable of alkylating phosphodiesters, 
which are structurally similar to the phosphylated Ser203 residue in the aged-AChE active site. 
Through computational methods (molecular docking, molecular dynamics, and tomodock), 
potential poses in AChE of a variety of quinone methide precursors (QMPs) were analyzed in 
silico to determine their putative efficacy in vitro.  
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1. Introduction 
1.1 Quinine Methide Precursors as Potential Therapeutics for OP Exposure 
Organophosphorus compounds (OPs), also known as phosphate esters, find use 
primarily as insecticides, herbicides, and chemical warfare agents. They are classified as some 
of the most toxic compounds ever developed due to their ability to cause fatal poisonings in 
sub-milligram dosages [1]. After characterization of OPs in 1932 by German scientist Willy Lange 
they were adapted for industrial use in the 1930s by another German scientist, Gerhard 
Schrader [2]. He created the first OP, tabun, as a pesticide and at the behest of the German 
government he created the first OP nerve agents, sarin and soman. (Figure 1) OPs have been 
used as weapons of war in Syria and Iraq as well as terrorist weapons in the Tokyo subway 
attack [3],[4]. Combined with accidental OP insecticide exposure thousands of people are hurt by 
OP compounds every year. Many OPs are now classified as weapons of mass destruction by the 
United Nations [5] and have been a threat since the 1990s because of their ease of synthesis and 
acute toxicity. Because OPs are an ongoing threat with limited treatment potential new 
treatment techniques need investigation.        
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Figure 1.1: Structures of OP nerve agents and insecticides 
OPs exert their toxic effect by inhibiting the enzyme acetylcholinesterase (AChE). This enzyme 
hydrolyzes the neurotransmitter acetylcholine (ACh) into choline and acetate by binding ACh to the 
Ser203 residue of the catalytic triad in the active site. (Figure 1.2) ACh is responsible for muscle activation 
and contraction as well as memory and arousal [6]. AChE serves to attenuate the ACh signal so nerve 
signals stop and the muscles can relax [6]. When the OP enters the active site of AChE the phosphonate 
binds the active serine residue of the enzyme’s’ catalytic triad. (Figure 1.2) In this form with the OP 
bound the enzyme is inhibited and unable to act on ACh. Once the OP is bound to Ser203 it undergoes a 
secondary reaction within several minutes to hours called aging. The aging process is when the bound 
OP is dealkylated, and the alkyl component leaves the active site of AChE, however, the phosphonate 
group remains bound to Ser203 permanently inhibiting the enzyme.  
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Figure 1.2: (A) AChE uses Serine-Histidine-Glutamate catalytic triad to hydrolyze AChE to acetate and 
choline. (B) OP inhibition of AChE due to P-O covalent bond. 
Before the aging process takes place, the inhibited enzyme can be regenerated into functioning 
AChE with administration of reactive oxime drugs which will reverse phosphylation. However, oximes 
are ineffective for treatment of the aged complex. The aged AChE results in a rapid buildup of ACh in 
neuromuscular synapses causing hyperarousal and extreme muscle contraction. Acute OP poisoning 
symptoms present as convulsions, paralysis, and death via asphyxiation. The window for treatment of 
OP poisoning is very short and depending on the size of the alkyl chain of the OP in question oxime 
treatment may not be adequate to reverse enough AChE prior to aging [12].  
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Preliminary Studies 
Quinone methide precursors (QMPs) are high energy reactive biological electrophiles that are 
thought to be powerful alkylating agents. (Figure 1.3) [7] QMPs have also been shown to participate in 
DNA-alkylation and previous research into the alkylation activity of their isomers and derivatives is 
available [8]. 
 
Figure 1.3: Proposed pyridine based quinone methide precursor alkylation reaction. The reactive 
intermediate, once generated in the active site will be able to bind the phosphonate oxygen, realkylating 
it and preparing the complex for oxime treatment.  
Of specific interest is a study by Bakke et al. which shows ortho- QMPs possess the ability to 
alkylate phosphodiester [9]. This is important because it suggests that QMPs possess the ability to 
realkylate aged AChE and make it susceptible to treatment with oxime-type drugs.  
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2. Initial Library 
2.1 Introduction 
A library of 39 quinone methide precursors (QMPs) for computational analysis was decided 
upon with collaborators. These compounds we based off the lead compound corriganine. (Figures 2.1) 
We modified the lead compound to contain electron withdrawing and electron donating substituents at 
the positions R4, R5 and R6. (Figures 2.1- 2.4) 
 
Figure 2.1: Corriganine scaffold with labeled substituent positions. 
4-Substituted Compounds
 
Figure 2.2: Library of quinone methide precursors.    
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5-Substituted Compounds 
 
Figure 2.3: Library of quinone methide precursors    
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6-Substituted Compounds 
 
 
Figure 2.4: Library of quinone methide precursors    
 
2.2 Preparation of structures for Docking 
To prepare these molecules for docking in the crystal structure of aged AChE each molecule was 
manually built in GaussView (Version 4.1.2) [1]. The B3LYP/6-311+G** level of theory was used for all 
calculations. Then they were all structurally optimized with Gaussian 09 with a Polarizable Continuum 
Model (PCM) of solvation in water [2], [3]. These optimizations yield the lowest energy conformation of the 
molecule which was then subjected to vibrational frequency analysis to confirm that the geometry was a 
minimum on the potential energy surface. To complete their preparation Merz-Kollman charge 
calculations were performed to each compound’s lowest energy conformation to build an electrostatic 
potential surface [4]. 
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These final geometries are reasonable approximations of their physical counterparts as the 
B3LYP density functional theory (DFT) method with the 6-311G** basis set has been shown to produce 
structural geometries very similar to those found via x-ray crystallography [5], [6].   
2.3 DOCKING  
Molecular Docking (MD) is a computational technique that is used to predict the predominant 
binding modes of a ligand within a protein active site by modeling the electrostatic interactions of the 
two. The ligand can move, flex, and rotate within the active site of the protein, which is held static. The 
simulation will move the ligand to increase favorable interactions in the active site and decrease steric 
clashes and unfavorable charge interactions. The resulting poses of the ligand within the active site can 
be used to predict ligand affinity for the active site.  
The prepared QMPs were docked in the active sites of 13 different poses of an artificially aged 
human AChE structure (PDB: 1B41). The structure of 1B41 was altered by the removal of the bound 
fasciculin peptide, cofactors, waters, and the addition of a phosphonate to the Ser203 residue. These 
frames were used because the shape of the active site of AChE changes slightly as the enzyme structure 
naturally oscillates slightly on a nanosecond timescale [7]. These 13 frames are static representations 
produced from a 5 nanosecond molecular dynamics simulation of AChE with a standard QMP in the 
active site so that the effects of induced fit could be analyzed with static enzyme structures, which 
reduces simulation complexity and lowers the required computational power. 
The QMPs were docked using Autodock4[8] in a 50x50x50 Å grid box positioned to contain the 
active site and part of the gorge leading from the surface of the enzyme to the active site. Then for every 
QMP 200 poses of the ligand in the active site for each of the receptor frames were saved, providing 
2600 total poses per QMP across all 13 frames. 
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After finishing these docking simulations, the compounds’ abilities to bind in the active site were 
scored by using the distance between the benzylic carbon (Figure 2.5) of the ligand and the oxygen of 
the phosphonate on the Ser203 residue. The bond necessary for the realkylation event is formed 
between these two atoms, and we hypothesize that the more poses where the distance between the 
two atoms is under 5 Å the higher the probability of the desired reaction occurring. 
 
Figure 2.5: The dotted line from the phosphonate oxygen to the benzylic carbon of the QMP is the 
distance used to score the putative realkylating activity of a ligand.  
2.4 DOCKING RESULTS 
After scoring the ligands using the phosphonate- benzylic carbon distances some interesting trends 
can be seen. The 4-substituted molecules scored better and have smaller distances overall than the 5- 
substituted molecules which in turn outperform the 6-substituted molecules.  
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Figure 2.6: Docking percentage affinity of ligands with substitutions at their 4 position for the active site 
of AChE. The score depicted above each bar is the percent of output poses where the benzylic carbon of 
the ligand is within 5 Å of the phosphonate oxygen that points into the active site which is always the 
closest. 
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Figure 2.7: Docking percentage affinity of ligands with substitutions at their 5 position for the active site 
of AChE. The score depicted above each bar is the percent of output poses where the benzylic carbon of 
the ligand is within 5 Å of the closest phosphonate oxygen. 
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Figure 2.8: Docking percentage affinity of ligands with substitutions at their 6 position for the active site 
of AChE. The score depicted above each bar is the percent of output poses where the benzylic carbon of 
the ligand is within 5 Å of the closest phosphonate oxygen.  
Qualitative analysis of the docking output which shows ligands in different conformations 
indicates that this trend of decreasing affinity is due to two effects, first the 5 and 6 position 
substitutions direct the ligands to spend more time interacting with residues in the bottleneck. (Figure 
2.9) This prevents the ligand from getting as close to the aged Ser203 residue as the 4 substituted 
frameworks. 
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Figure 2.9: 6-NO3-corriganine is interacting with the residues Phe295, Phe297, Phe338, and hydrogen 
bonding with Tyr124. These residues are part of the bottleneck section of the binding pocket that is 
located between the opening and the catalytic triad. The steric effect of the 5 and 6 position 
substituents direct them to the bottleneck area. 
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Ligand Score 
R=4-Cl 71.0 
R=4-Br 66.9 
R=4-F 65.8 
R=4-CH3 65.6 
R=5-F 65.4 
R=5-Br 64.0 
R=6-F 63.7 
R=4-CH2CH3 62.8 
R=4-CF3 62.8 
R=5-CH3 62.8 
R=5-Cl 62.6 
R=5-CH2CH3 62.2 
R=5- N(CH3)2 61.4 
R=5-CF3 60.2 
R=6-CH3 59.1 
R=4-CH(CH3)2 58.9 
R=5- CH(CH3)2 58.8 
R=5-OCH3 57.9 
R=6-Cl 57.9 
R=4-CN 56.8 
R=6-Br 54.1 
R=4-N(CH3)2 54.0 
R=4-OCH3 54.0 
R=4-NH2 53.6 
R=6-CN 51.7 
R=6-OH 51.1 
R=6-NH2 50.5 
R=5-NH2 49.5 
R=5-CN 48.7 
R=4-OH 48.3 
R=6-CH2CH3 47.8 
R=6-CF3 47.4 
R=6-OCH3 45.6 
R=5-OH 45.2 
R=6-CH(CH3)2 41.5 
R=6-N(CH3)2 39.3 
R=4-NO2 21.9 
R=5-NO2 19.3 
R=6-NO2 8.8 
Table 2.1: ligands ranked by percent of the 2600 docking poses with distances of 5 Å or lower to the 
phosphonate oxygen.    
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The expected distribution of these high performing ligands can be seen. The majority of 
measured distances are within the 3-4 Å distance which is optimal, and the number of poses found in 
outer regions of the binding pocket are minimal. (Figure 2.8) This is the localization that would be 
desirable for a good realkylator to exhibit in vitro as time spent near the phosphylated serine should 
increase the likelihood of a reaction.  
 
Figure 2.10: Here the 2600 total poses for each ligand have been sorted by their distance from the 
phosphonate. Only the top five compounds are pictured.  
MOLECULAR DYNAMICS                            
Molecular dynamics (MD) is a computational technique that models ligand interactions within a 
fluid and dynamic model over a set period of time. Allowing both ligand and enzyme to move with 
constraints. Allowing this additional motion creates a better approximation than molecular docking of 
the evolution of the system over time. For this set of MD calculations, water was designated as the 
solvent, and the three most energetically favorable poses from molecular docking are used as starting 
geometry for the system. All 13 frames of the prepared AChE were used as MD starting geometries 
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resulting in a total 39 MD simulations for each ligand. This system has some energy outliers, so a 
steepest descent minimization is run for 500 steps followed by 500 steps of a conjugate gradient 
minimization calculation to push the system to a more accurate energy level. The system is put through 
another 1000 steps of steepest descent minimization and 1500 steps of conjugate gradient minimization 
before beginning the actual MD simulation with a timescale of 1 nanosecond.  
As the ligand moves its time spent in three designated sections of AChE; the gorge mouth, the 
bottleneck, and the active site, are used to determine if it would be an effective therapeutic for use in 
regenerating the enzyme. These sections of the enzyme are labeled based on their distance from the 
phosphylated Ser203 residue, which were empirically derived from initial simulations. 
Binding Pocket Location Angstroms from Phosphonate Oxygen 
Active Site 0-5 Å 
Active site to Bottleneck 5-7 Å 
Bottleneck 7-9.5 Å 
Gorge Mouth 15 Å+ 
Table 2.2: Distances between benzylic carbon and phosphonate oxygen that form scoring criteria for MD 
simulation 
The results of molecular dynamics calculations were compiled to yield quantitative data on the 
ligands’ binding preferences as a percent of poses with distances below 5 Å.                                                 
2.6 Molecular Dynamics Results 
Tables of results for each ligand were produced by measuring the distance from the benzylic 
carbon of the ligand to the oxygen of the phosphylated Ser203. The MD simulation produces 500 
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snapshot frames over 1 nanosecond for each cluster. The typical total of still frames output from MD 
was 19500 frames gathered from each of the 3 clusters for each of the 13 frames. Each frame was 
sorted into the bins based on their ligand to Ser203 distances. The number of frames in each bin was 
divided by the total frames for the ligand and shown as a percent of frames in a specific bin. 
Substituent % Active 
Site 
% Between 
AS and BN 
% Bottleneck % Between 
BN and GM 
% Gorge 
Mouth 
4-OH 35.22 19.16 19.01 3.08 22.46 
4-OCH3 54.01 20.1 4.26 1.19 20.44 
4-CH4 33.81 23.91 27.23 3.44 11.59 
4-NH2 47.23 23.41 9.69 2.36 17.2 
4-N(CH3)2 44.38 22.21 19.11 5.73 8.57 
4-CN 50.68 11.83 13.84 4.91 17.33 
4-NO2 24.95 16.87 22.99 2.48 30.68 
4-CF3 44.27 13.83 13.28 3.58 24.96 
4-CH2CH3 68.29 8.99 9.54 2.67 10.51 
4-CH(CH3)2 51.48 14.9 3.78 1.77 27.97 
4-F 54.78 12.33 9.75 7.16 15.98 
4-Cl 63.85 26.28 0.95 1.35 7.57 
4-Br 48.94 28.76 9.27 2.28 10.32 
 
Table 2.3:  4-substituted ligand populations as percent of distances measured to closest aged 
phosphonate oxygen. (AS)=active site (BN)= bottleneck, (GM)= gorge mouth. 
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Substituent % Active 
Site 
% Between 
AS and BN 
% Bottleneck % Between 
BN and GM 
% Gorge 
Mouth 
R=5-OH 76.7 13.3 6.0 0.4 3.6 
R=5-OCH3 51.0 24.9 7.1 2.8 13.9 
R=5-CH4 60.3 17.2 2.4 1.4 18.8 
R=5-NH2 79.3 12.6 3.5 2.4 2.3 
R= N(CH3)2 41.3 31.1 10.2 4.6 12.9 
R=5-CN 38.1 32.9 3.3 2.2 21.7 
R=5- NO2 22.5 30.9 16.0 2.3 25.5 
R=5- CF3 39.8 20.9 11.5 3.7 23.1 
R=5- CH2CH3 47.1 30.0 6.5 0.6 15.8 
R=5- CH(CH3)2 46.8 18.0 8.0 0.4 25.6 
R=5-F 62.2 23.7 1.2 0.2 12.7 
R=5-Cl 54.4 27.3 1.1 1.9 15.0 
R=5-Br 52.0 23.8 3.6 2.2 18.4 
 
Table 2.4:  5-substituted ligand populations as percent of distances measured to aged phosphonate 
oxygen. (AS)=active site (BN)= bottleneck, (GM)= gorge mouth. 
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Compound 
Name 
% Active 
Site 
% Between 
AS and BN 
% Bottleneck % Between 
BN and GM 
% Gorge Mouth 
R=6-OH 47.3 28.6 9.7 0.3 8.9 
R=6-OCH3 53.2 8.7 8.2 3.7 21.1 
R=6-CH3 51.8 13.2 14.9 1.3 13.7 
R=6-NH2 43.3 20.5 22.1 1.8 5.8 
R=6-N(CH3)2 22.2 30.4 14.7 3.3 21.8 
R=6-CN 29.0 31.1 10.1 0.9 13.2 
R=6-NO2 30.4 20.9 10.8 4.1 22.5 
R=6-CF3 44.2 16.7 6.7 2.2 17.7 
R=6-CH2CH3 45.0 9.6 12.7 1.7 17.9 
R=6-CH(CH3)2 45.7 11.1 11.3 1.5 20.2 
R=6-F 39.2 33.9 8.7 0.7 11.4 
R=6-Cl 32.9 37.3 11.0 1.1 11.2 
R=6-Br 28.7 37.5 13.7 2.1 11.6 
 
Table 2.5:  6-substituted ligand populations as percent of distances measured to aged phosphonate 
oxygen. (AS)=active site (BN)= bottleneck, (GM)= gorge mouth. 
Interestingly the top preforming ligands in docking were not conserved in MD, the 5-halogen 
substituted corriganine were best in docking but in MD the 5-OH, 5-CH3, and 5-NH3 were the best 
preforming ligands. These ligands spend a significant amount of time hydrogen bonding with the 
methyl-phosphonate and Glu202. (Figures 2.11, 2.12, 2.13, 2.14) They also show frequent Trp86 pi-pi 
interaction with both rings of the ligand. The reason for this discrepancy between some docking and MD 
results are likely because MD is a more accurate predictor of enzyme-ligand interaction with its fluid 
protein structure which can move in response to the presence of the ligand, where docking uses only 
static poses of the protein. 
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Ligand Score 
R=5-NH2 79.3 
R=5-OH 76.7 
R=4-CH2CH3 68.3 
R=4-Cl 63.9 
R=5-F 62.2 
R=5-CH3 60.3 
R=4-F 54.8 
R=5-Cl 54.4 
R=4-OCH3 54.0 
R=6-OCH3 53.2 
R=5-Br 52.0 
R=6-CH3 51.8 
R=4-CH(CH3)2 51.5 
R=5-OCH3 51.0 
R=4-CN 50.7 
R=4-Br 48.9 
R=6-OH 47.3 
R=4-NH2 47.2 
R=5-CH2CH3 47.1 
R=5-CH(CH3)2 46.8 
R=6-CH(CH3)2 45.7 
R=6-CH2CH3 45.0 
R=4- N(CH3)2 44.4 
R=4-CF3 44.3 
R=6-CF3 44.2 
R=6-NH2 43.3 
R=5-N(CH3)2 41.3 
R=5-CF3 39.8 
R=6-F 39.2 
R=5-CN 38.1 
R=4-OH 35.2 
R=4-CH3 33.8 
R=6-Cl 32.9 
R=6-NO2 30.4 
R=6-CN 29.0 
R=6-Br 28.7 
R=4-NO2 25.0 
R=5-NO2 22.5 
R=6-N(CH3)2 22.2 
Table 2.6: Molecular Dynamics ligand scores (% of poses within 5 Å). 
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The trend of low active site affinity among 6-position substitutions seen in docking was 
maintained in MD. The preference of these ligands to interact with the bottleneck predicted by docking 
continued to be a factor, which increases the likelihood that these 6-substituted ligands will perform 
poorly in vitro.  
Substituent Average 
Score 
Electrophilic aromatic directing Properties 
NH2 57 Strong electron donating 
CH2CH3 53 Weak electron donating 
OH 53 Strong electon donating 
OCH3 53 Strong electron donating 
F 52 Weak electron withdrawing 
Cl 50 Weak electron withdrawing 
CH3 49 Weak electron donating 
CH(CH3)2 48 Weak electron donating 
Br 43 Weak electron withdrawing 
CF3 43 Strong electron withdrawing 
CN 39 Strong electron withdrawing 
N(CH3)2 36 Strong electron donating 
NO2 26 Strong electron withdrawing 
 Table 2.7: Here the scores (% of distances <5 Å) for each substituent type from the MD simulation were 
averaged from the 4, 5, and 6 position tests and the substituents were then ranked where the top NH2 
group is the best at directing ligands to the active site and the bottom NO2 is the worst. Each substituent 
electrophilic aromatic directing properties are also displayed.   
The three worst preforming substituent groups, NO2, N(CH3)2, and the nitrile groups were poor 
in docking and MD, because their bulky substituents kept them interacting with residues in the gorge 
mouth and bottleneck (Figure 2.9), as evidenced by their low percent of distances near the 
phosphonate. (Tables 2.6, 2.7) In terms of groups that modify the electron density of the pyridine ring, 
the electron donating groups (NH2, CH2CH3, OH, OCH3) all performed well while three of the worst 
groups were exclusively strong electron withdrawing groups, except for N(CH3)2, indicating that strong 
electron donating groups are better at directing ligands into the active site.  
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Figure 2.11: MD output pose for 5-OH-corriganine in the active site of AChE.  
 
Figure 2.12: MD output pose for 4-CH2CH3-corriganine (blue).  
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Figure 2.13: MD output pose for 5-NH2-corriganine (blue).    
 
 
Figure 2.14: MD output pose for 4-Cl-corriganine (blue).  
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 The best performing ligands (Figures 2.11, 2.12, 2.13, 2.14) all occupy a similar location in the 
active site, above the Glu202 and to the left of the phosphonate (looking from the phosphonate 
outward). This is likely because this is the location with the densest cluster of hydrogen bond donors and 
accepting residues, namely Ser203, Glu202, and Tyr133.  
 The 3 position hydrogen bonds with the methyl-phosphate, while the 5-OH forms a hydrogen 
bond with the carbonyl oxygen of the His452 residue. (Figure 2.11) The pyrrolidine hydrogen bonds with 
the Tyr341 residue. The pyrrolidine hydrogen bonds with Glu202, while the hydroxyl forms a hydrogen 
bond with Tyr137. Trp86 pi stacking occurs in almost all frames. The ethyl group is within Van Der Waals 
interaction distance of the Lys134 residue. (Figure 2.12) The amino group hydrogen bonds with Tyr137 
while the pyrrolidine hydrogen bonds with the phosphate and the hydroxyl forms a hydrogen bond with 
Glu202. (Figure 2.13) The 3-OH group hydrogen bonds with Tyr137 while the pyrrolidine nitrogen hydrogen 
bonds with the Glu202 residue. (Figure 2.14) 
Across all frames with 4-Cl-corriganine (Figure 2.14) the chlorine atom does not exhibit any 
discrete interactions, however, its position may sterically discourage other positions with less favorable 
distances to the phosphonate. Additionally, the weak electron-withdrawing properties of halide 
substitution could be lessening the effect of the Trp86 pi-pi interactions which would allow the ligand to 
pull away from that residue toward the phosphonate.  
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3 Tomographic Docking 
3.1 INTRODUCTION 
Tomodock is a program provided free by researchers at the University of Warwick in the UK that 
utilizes sequential Autodock Vina docking simulations to analyze interactions between protein residues 
and ligands along the length of deep enzyme binding pockets [1].  
Tomodock allows the user to specify two or more points marking the opening and the bottom of 
the binding pocket. Several grid boxes whose dimensions and quantity are specified by the user are 
spaced evenly between the two endpoints and run sequentially. At each depth the chosen ligand can 
interact with only the residues that intersect the gridbox and the lowest energy pose is found and saved. 
This will yield a series of poses from the mouth of the pocket to the bottom showing a lowest energy 
path of diffusion.  
Tomodock was used to reveal interactions between Corriganine and the residues along the 
binding pocket of AChE. The interactions that Corriganine is seen to favor as it moves down the active 
site can be compared to the interactions that a non- resurrecting QMP favors during a simulation to 
isolate those interactions that serve to aid QMP diffusion to the methyl-phosphonate bound serine, and 
those that that inhibit movement down the pocket. Once known we can then use a combination of 
further in silico and in vitro techniques to design QMPs intelligently, so that they will better navigate the 
length of the binding pocket and realkylate the phosphonate with greater speed and reliability.   
3.2 TOMODOCK ANALYSIS METHODS 
For our simulations we used six gridboxes to cover the entire topography of the binding pocket. 
Boxes had initial coordinates x-60 y-37.9 z-42.7 and final coordinates x-48.8 y-37.9 z-42.7 (Figure 3.1) 
and box dimensions were 16 angstroms square and 6 angstroms tall. The simulation was run with three 
different versions of Corriganine, a protonated amine, a zwitterionic form, and a neutral form. The 
simulation was run in thirteen different frames of human acetylcholinesterase (PDB 1B41). These frames 
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were collected from an MD simulation of the enzyme to represent the dynamic motion it would exhibit 
in solution. Some of the outputs from these frames were unsuitable because the bottleneck was 
occluded by residues, and these were discarded.  
3.3 ANALYSIS AND RESULTS 
The positive, neutral and zwitterionic states exhibited similar patterns of interaction as they 
moved down the active site. (Figures 3.3, 3.4, and 3.5)  The Zwitterionic form has a slightly lower overall 
binding energy, likely because of the greater amount of hydrogen bonds it can form in the active site. 
 
 
 
 
 
 
 
 
 
 
Figure 3.1: Starting Position of Tomodock gridbox (Left) and the ending point (Right).  
 
 
Figure 3.2: Pictured are the three charge states of corriganine that were tested in Tomodock.  
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As the positively charged corriganine moves down the gorge into the active site it avoids the 
oxyanion hole (blue) except for a transient hydrogen bond with Ser125. (Figure 3.3) The positive 
corriganine also has heavily conserved pi-pi interaction with the Trp86 residue in the cation binding 
region (orange).  
The neutral Corriganine ligand moves down the gorge into the active site while avoiding the 
oxyanion hole (blue) and has heavily conserved pi stacking with the Trp86 residue in the cation binding 
region (orange). (Figure 3.4) The ligand forms a hydrogen bond with Tyr124. Like the positive ion 
orientations but with no Ser125 interaction. The zwitterion has a similar path to the positive ion however 
it avoids interaction with Ser125. 
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Figure 3.3: Results from each of the Tomodock simulations with positively charged corriganine. The 
catalytic triad surface is red, the acyl loop is depicted here in green, and the purple area is the omega 
loop/ active site. 
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Figure 3.4: Results from each of the Tomodock simulations with neutral charged corriganine. The 
catalytic triad surface is red, the acyl loop is depicted here in green, and the purple area is the omega 
loop/ active site. 
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Figure 3.5: Results from each of the Tomodock simulations with zwitterion form of corriganine. The 
catalytic triad surface is red, the acyl loop is depicted here in green, and the purple area is the omega 
loop/ active site. 
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The binding energies of corriganine in these charge states differs, with the zwitterion having the 
lowest, followed by the positively charged corriganine. (Figure 3.6) This predicts that ligands with better 
or more hydrogen bonding groups or ionic interactions will have more favorable interactions within the 
binding pocket, and that future ligand research should utilize this knowledge.   
 
Figure 3.6: Autodock Vina binding energies outputs for each of the charge states of corriganine as it 
diffuses down the active site of human AChE. Each numbered gridbox is a new Autodock Vina simulation 
at a lower xyz coordinate between the entrance of the binding pocket to the catalytic triad.   
 The binding energies of the three charged states indicates that the zwitterion form had the 
lowest energy states over the course of the simulated diffusion of the ligand to the active site. 
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4 Conclusions and Future Work 
4.1 Conclusion 
The ligands that scored the best in MD simulation results are the best candidates for realkylating 
methyl-phosphonate aged AChE. The trend among the best scoring ligands from MD was for additional 
hydrogen bonding groups (5-NH2 and 5-OH) or a 4-CH2CH3 group. The rest of the top ten compounds 
had halide or methyl substitutions however their score was far below the top three compounds. 
The 5-OH and 5-NH3 substituted ligands (scores 70.3 and 61.3 respectively) show a greater 
affinity for Glu202 than other residues in the active site. This helps position the ligand more closely to the 
phosphonate and minimize the distance from the benzylic carbon to the phosphonate, increasing the 
probability of the desired reaction.     
The 4-CH2CH3 substitution was found most often interacting with the two groups of hydrophobic 
residues in the active site (Phe338, Try341, Trp86, and leu130) these interactions pull the pyridine ring away 
from the Trp86 residue and toward the phosphonate. pi-pi interactions between the heterocycles of the 
Trp86 residue and the ligand pyridine pull the ligand away from the phosphonate and it appears that the 
4-CH2CH3 substituent counteracts this. (Table 2.7)     
Among the compounds with the lowest affinity for the active site, large sterically hindering 
substituents like the nitro, dimethylamine, and isopropyl groups scored the lowest. Additionally, 
substituents in the 6 positions were observed to perform poorly.  Visual analysis of these poor 
performers showed that they spend more time interacting with residues in the gorge and bottleneck 
areas on the side of the active site opposite the phosphonate.    
Analysis of the diffusion of the three charge states of corriganine via the Tomodock program 
revealed that the ligands prefer to avoid the oxyanion hole portion of the active site. The ligands also 
move down toward the cation binding region where piperidine pi-pi interaction with the Trp86 residue is 
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highly conserved. There is a notable lack of the expected ligand interaction with the phosphonate, this 
may be because an additional gridbox centered behind the phosphonate was not included. Lowering the 
bottom gridbox center and increasing the number of gridboxes may remedy this problem in future 
simulations.  
4.2 Future Work 
In the search for a better realkylating compound studies such as this one which utilize 
computational methods to analyze a library of compounds for their affinity for the active site have 
shown their ability to predict molecules that have in vitro activity. This library yielded some promising 
ligands, namely 5-OH-corriganine, 5-NH3-corriganine, 4-CH2CH3-corriganine, and 4-Cl-corriganine, that 
will be passed on to our collaborators to be synthesized and tested for activity.  
Further analysis of these compounds in other charge states is warranted as the active site of 
AChE may alter the protonation of the ligand as it diffuses down the gorge and interacts with the active 
site. New ligands with strong electron donating groups should be investigated to find a ligand with 
better affinity for the active site. Additionally, computational analysis of more libraries of compounds 
with different substituents and substituent patterns on corriganine are a likely source of the next 
corriganine like ligand. Also, use of the Tomodock computational analysis technique may also serve to 
greater elucidate the manner in which ligands interact and diffuse down to the active site of AChE. 
